From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards

From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards

Abstract Background A comprehensive understanding of cancer has been furthered with technological improvements and decreasing costs of next-generation sequencing (NGS). However, the complexity of interpreting genomic data is hindering the implementation of high-throughput technologies in the clinica...

Full description

Bibliographic Details
Main Authors: Júlia Perera-Bel, Barbara Hutter, Christoph Heining, Annalen Bleckmann, Martina Fröhlich, Stefan Fröhling, Hanno Glimm, Benedikt Brors, Tim Beißbarth
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Genome Medicine
Subjects:
Genomic report
Personalized treatment
Cancer genomics
Targeted therapies
Predictive biomarkers
Molecular tumor board
Online Access:http://link.springer.com/article/10.1186/s13073-018-0529-2

Internet

http://link.springer.com/article/10.1186/s13073-018-0529-2

Similar Items